Larium 250mg Tablet
By Larium
Rx
4 Tablet in a Strip

Composition
Mefloquine(250mg)

Manufacturer - Roche Products India Pvt Ltd
1503, 15th Floor, 'The Capital', Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Expires on or after
September, 2025

liver
When using Larium 250mg Tablet, it is essential to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication, so consulting your doctor before starting treatment is crucial. It is also important to note that using Larium 250mg Tablet is not advised for individuals with severe liver disease.

kidney
Limited data exists on using Larium 250mg Tablet in kidney disease patients. Consult your doctor for guidance.

alcohol
Caution is advised when consuming alcohol with Larium 250mg Tablet. Consult your doctor.

driving
Larium 250mg Tablet may lead to side effects like dizziness, loss of balance, and mental issues, impacting driving ability.

pregnancy
Larium 250mg Tablet may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Kindly consult your doctor.

breastfeeding
Larium 250mg Tablet is considered safe for use during breastfeeding based on limited human data. The drug is not likely to pose a significant risk to the baby.
Habit Forming | No |
Chemical Class | 4-Quinolinemethanol derivative |
Therapeutic Class | ANTI MALARIALS |
Action Class | Antimalarial- others |
₹5.98
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024